U.S. to Impose 100% Tariff on Branded Drugs Unless Firms Build Plants
President Trump says a 100% tariff will apply to branded pharmaceutical imports from Oct. 1, unless the companies have begun building manufacturing plants in the U.S.
Understand the policies and regulations shaping today’s business environment. This section covers new laws, antitrust actions, compliance challenges and government initiatives that influence corporate strategies and market competition. We deliver timely updates and expert insight to help readers anticipate changes, manage risks and seize opportunities created by evolving regulatory frameworks around the world.
President Trump says a 100% tariff will apply to branded pharmaceutical imports from Oct. 1, unless the companies have begun building manufacturing plants in the U.S.
China has ordered major tech firms to stop buying Nvidia’s RTX Pro 6000D chips, prompting CEO Jensen Huang to express disappointment and highlight growing geopolitical risk.